NOVARTIS

Advertisement
Jan 31 2025BUSINESS

Big Wins for Big Pharma: Novartis Bounces Back

In the fourth quarter of 2024, a big Swiss drug maker, Novartis, beat expectations but missed its own yearly goals. It announced a huge 16% jump in net sales. That's $13. 2 billion, way more than the estimated $12. 795 billion. The company's adjusted core operating income also surpassed expectation

reading time less than a minute
Sep 17 2024ENVIRONMENT

A New Horizon for Offshore Wind Power in the Gulf of Maine

The US Department of Interior has set an auction date of October 29th for the first-ever sale of offshore wind energy leases in the Gulf of Maine. This significant move marks a major step forward in the country's efforts to transition to cleaner, renewable energy sources. The auction, which includes

reading time less than a minute
Sep 16 2024HEALTH

The Radiopharmaceutical Revolution: A New Era in Cancer Treatment?

As the world continues to grapple with the complexities of cancer treatment, a new wave of innovation is emerging in the form of radiopharmaceuticals. These groundbreaking medications have the potential to revolutionize the way we approach cancer care, offering a targeted and minimally invasive appr

reading time less than a minute